About Us

Businesses

People

Citizenship

Newsroom

Bain Capital, LP is one of the world’s leading private multi-asset alternative investment firms with approximately $105 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact ir@baincapital.com.

Sign on to your account

Questions?
Call Us: 24 x 7 Global Phone Support
Email Us: support@intralinks.com
Meet the Bain Capital Investor Relations team
Logo Logo

Centrient
COVID-19 Response

Donating masks, disinfection supplies and local resources to healthcare facilities, public institutions and vulnerable communities across Europe and Asia

From medicine to masks

Centrient Pharmaceuticals is donating almost 60,000 masks to support healthcare workers in hospitals in the Netherlands and Spain as well as local health authorities in Yushu, China.

Press release

Centrient Pharmaceuticals donating 30,000 masks to support healthcare workers in hospitals in the Netherlands and Barcelona, Spain

Supporting vulnerable families with essentials

In India, the Toansa plant made a donation of ~6000€ to the District Red Cross to assist community management of COVID-19. In addition, the company also worked with a local NGO to supply groceries for 10 days for 100 families.

About Centrient

Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals, producing and selling intermediates and active pharmaceutical ingredients (APIs), as well as their own tablets, capsules and other finished dosage forms (FDFs).

Visit centrient.com

Explore more of what our companies are doing to combat COVID-19 and support our communities

Hit enter to search or ESC to close